Are we finally nearing a treatment for Alzheimer’s?

Back in November, researchers hailed the dawn of a new era of
Alzheimer’s therapies. After decades of failure, a clinical trial
finally confirmed that a drug, lecanemab, was able to slow
cognitive decline in patients with early stages of the disease. The
result may have been modest – a reduction in the decline in
patients’ overall mental skills by 27% over 18 months – but it
could not be more significant in the journey towards better
understanding and treating the disease. Ian Sample speaks to Prof
Nick Fox about the clinical trial results, if this could be the
first of many new Alzheimer’s therapies, and whether we could one
day see a cure.. Help support our independent journalism at
theguardian.com/sciencepod